Prof. Dr. Michael Laxy
Professor
| Professorship of Public Health & Prävention Technical University of Munich Georg-Brauchle-Ring 60/62 80992 Munich | Room: M-510 Telephone: +49 (0) 89/289 24977 E-Mail: michael.laxy(at)tum.de |
Profile
Prof. Dr. Michael Laxy leads the Professorship of Public Health and Prevention at the TUM School of Medicine and Health. Before his appointment at TUM, he led the working group on ‘Economics of Diabetes’ at the Institute of Health Economics at the Helmholtz Zentrum München.
Prof. Laxy studied public health (MPH), epidemiology (MSc), economics and sports science (BSc) at the Ludwig-Maximilians-University Munich (LMU), the Fernuniversität Hagen and at TUM. During his PhD at LMU focusing on economic aspects of diabetes care, he held research positions at the Helmholtz Zentrum München and the University of Cambridge. From 2017 to 2018 he was a Harkness Fellow for Health Care Policy and Practice at the US Centers for Disease Control and Prevention and since 2019, he serves as an adjunct professor at Emory University – Rollins School of Public Health. In December 2020, Prof. Laxy was appointed by TUM as professor for ‘Public Health and Prevention’.
Prof. Laxy’s research focuses the evaluation of prevention measures and health policies concerning their effectiveness and efficiency and on the analysis of determinates and consequences of non-communicable diseases on population level.
Selected funded projects
Research network for design and evaluation of adolescent health interventions and policies in Sub-Saharan Africa (DASH), German Ministry of Research and Education, 2023-2028, Amount: 1.05 million € (Laxy) / 7.5 million € (project total), Role: PI & WP lead
Reducing nutrition-related NCDs in adolescence: interventions to boost diet quality in SSA (NUTRINT), Horizon Europe, Amount: 0.19 million € (Laxy) / 4.3 million € (total project), Role: PI & WP lead
Cost-effectiveness of Public Health Screening for Pre-symptomatic Type 1 Diabetes with and without Treatment for Prevention of Typ 1 Diabetes (SCREEVA), Leona M. and Harry B. Helmsley Charitable Trust, 2023-2025, Amount: 0,24 million € (Laxy), Rolle: PI
Economics of diabetes prevention and care (ECON-Diabetes), German Ministry of Research and Education/German Center for Diabetes Research, 2023-2025, Amount: 0.27 million €, Role: PI and project lead
Adiposity Care and Health Therapy (ACHT), German Federal Joint Committee (G-BA), 2019-2023, Amount: 0.42 million € / 4.0 million € (project total) 4, Role: Evaluator
Moving to next generation healthcare: Using real world data to target prevention of diabetes complications (MNGHC), German Ministry of Research and Education/German Center for Diabetes Research, 2021-2022, Amount: 160,000€, Role: PI and project lead
JPI-Policy Evaluation network (PEN), German Ministry of Research and Education, 2019-2022, Amount: 108,000€ (project total 1,8 million €), Role: PI & WP co-lead
Selected publications
Emmert-Fees, K.M.F., Amies-Cull, B., Wawro, N., Linseisen, J., Staudigel, M., Peters, A., Cobiac, L.J., O'Flaherty, M., Scarborough, P., Kypridemos, C. and Laxy, M.: Projected health and economic impacts of sugar-sweetened beverage taxation in Germany: A cross-validation modelling study. PLoS Medicine 2023, 10.1371/journal.pmed.1004311
Fan, M., Stephan, A.J., Emmert-Fees, K, Peters, A., Laxy, M.: Health and economic impact of improved glucose, blood pressure and lipid control among German adults with type 2 diabetes: a Modeling Study. Diabetologia 2023, 10.1007/s00125-023-05950-3
Pedron, S., M. Hanselmann, J. Burns, A. Rich, A. Peters, M. Heier, L. Schwettmann, J.H. Bor, T. Bärnighausen and M. Laxy.: The effect of population-based blood pressure screening on long-term cardiometabolic morbidity and mortality in Germany: A regression discontinuity analysis. PLoS Medicine, 2022, 10.1371/journal.pmed.1004151
Emmert-Fees, K., Karl, F., von Philipsborn P., Rehfuess, E., Laxy M.: Simulation Modelling for the Economic Evaluation of Population-Based Dietary Policies: A Systematic Scoping Review. Advances in Nutrition 2021, 10.1093/advances/nmab028
Pedron, P., Kurz, CF., Schwettmann, L., Laxy, M.: The Effect of BMI and Type 2 Diabetes on Socioeconomic Status: A Two-Sample Multivariable Mendelian Randomization Study. Diabetes Care 2021, 10.2337/dc20-1721
Laxy M, Becker J, Kähm K, Holle R, Peters A, Thorand B, et al. Utility Decrements Associated With Diabetes and Related Complications: Estimates From a Population-Based Study in Germany. Value in Health 2021, 10.1016/j.jval.2020.09.017
Laxy, M., Zhang, P., Ng, B., Shao, H., Ali, MK., Albright, A., Gregg E.: Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact. Applied Health Economics and Health Policy 2020, 10.1007/s40258-020-00565-w
Kurz, C., Laxy, M.: Association of Obesity with Health Care Costs: A Mendelian Randomization study. Medical Decision Making 2020, 10.1177/0272989X20905809
Laxy, M., Schöning, V.M., Kurz, C., Holle, R., Peters, A., Meisinger, C., et al. Performance of the UKPDS outcomes model 2 for predicting death and cardiovascular events in patients with type 2 diabetes mellitus from a German population-based cohort. Pharmacoeconomics 2019, 10.1007/s40273-019-00822-4
Laxy, M., Wilson, E., Boothby, C., Griffin, S.: Incremental costs and cost-effectiveness of intensive treatment in patients with screen-detected type 2 diabetes in the ADDITION-UK trial: An update with empirical trial-based cost data. Value in Health 2017, 10.1016/j.jval.2017.05.018
Pubmed Link: https://pubmed.ncbi.nlm.nih.gov/?term=Laxy+M&sort=date
